Leika Medical Equipments Ltd. has been acquired by Angus Capital
May 2024 — The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.
Leika Medical Equipments Ltd. is a family-owned business specializing in the distribution and rental of wound care and pain relief products. The company provides high-end therapeutic equipment compliant with the established standards.
Angus Capital is a Canadian private equity fund specializing in the acquisition of SMEs in traditional industries. Its team is led by a group of multidisciplinary entrepreneurs who are actively involved in executing the growth plans of the companies in which they invest.
Our role in the transaction
Oaklins’ team in Canada advised the shareholders of Leika on the sale of the business to Angus Capital.
Jean-Francois Tanguay
Shareholder, Leika Medical Equipments Ltd.
Sprechen Sie mit dem Deal Team
Transaktionen
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Mehr erfahrenKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Mehr erfahrenGroGlass has been acquired by Apogee Enterprises
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading US provider of architectural building products, services and high-performance coated materials, has acquired GroGlass, a Latvia-based developer and manufacturer of high-performance anti-reflective and UV-protective glass coatings. The acquisition brings GroGlass’ differentiated coating technologies and materials science expertise into Apogee’s performance surfaces segment, broadening its product offering and market reach while expanding its manufacturing and R&D presence in Europe.
Mehr erfahren